SCHEDULE 13G

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

February 17, 2015

Accession Number

0001019056-15-000234

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →